1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
The Marygold Companies, Inc. (TMC), parent of the fund's general partner, agreed to sell itself to Madison Dearborn Partners (MDP) in an all-cash transaction, becoming a privately held company. The filing says the deal is expected to close in the first half of 2027 or earlier, subject to conditions including TMC stockholder approval, regulatory approvals and change-of-control approvals, and that there is no guarantee it will be completed.
TMC announced a definitive agreement with MDP on September 25, 2026.
TMC is the sole shareholder of USCF Investments, Inc., which is the sole member of United States Commodity Funds LLC, the fund's general partner.
Expected closing: first half of 2027 or earlier, subject to customary conditions.
Upon closing, TMC's common stock will no longer be listed on the New York Stock Exchange.
The Marygold Companies, parent of USCF Investments and sponsor USCF of the USCI funds, agreed on September 25, 2026 to be acquired in an all-cash deal by private equity firm Madison Dearborn Partners and become a privately held company. Closing is expected in the first half of 2027 or earlier, subject to TMC stockholder approval, regulatory approvals and change-of-control approvals, and the filing says there is no guarantee the deal will be completed.
Definitive agreement with Madison Dearborn Partners announced September 25, 2026, for an all-cash transaction
Expected to close during the first half of 2027 or earlier, after customary closing conditions are met
TMC common stock would stop trading on the New York Stock Exchange after the deal closes
After closing, TMC and MDP plan to carry out TMC's previously announced strategy to refocus USCF's business
Southland Holdings received a notice from NYSE American on September 23, 2026, saying it is not in compliance with stockholders' equity listing standards after reporting a $248.2 million stockholders' deficit at June 30, 2026. The shares and warrants remain listed for now, but the company must submit a compliance plan by October 23, 2026, and regain compliance by March 23, 2028, or face delisting proceedings.
NYSE American notice received September 23, 2026, citing Sections 1003(a)(i) and 1003(a)(ii) of the Company Guide
Stockholders' deficit of $248.2 million at June 30, 2026; company reported net losses in its last three fiscal years
Compliance plan due October 23, 2026; compliance deadline March 23, 2028
Shares (SLND) and warrants (SLND WS) continue trading on NYSE American for now
On September 25, 2026, The Marygold Companies, Inc. (TMC), which indirectly owns the general partner of this fund, agreed to be acquired by Madison Dearborn Partners in an all-cash transaction that would take TMC private. The deal is expected to close in the first half of 2027 or earlier, but it depends on TMC stockholder, regulatory and change-of-control approvals, and the filing says it may not be completed. TMC and MDP plan to refocus the general partner's business after closing.
On September 25, 2026, TMC announced a definitive agreement with Madison Dearborn Partners for an all-cash transaction.
TMC owns USCF Investments, Inc., which is the sole member of United States Commodity Funds LLC, the general partner of the fund.
Expected close is the first half of 2027 or earlier, subject to TMC stockholder, regulatory and change-of-control approvals.
After completion, TMC common stock would no longer be listed on the New York Stock Exchange.
The Marygold Companies (TMC), which indirectly owns United States Commodity Funds LLC, the general partner of United States Gasoline Fund (UGA), agreed on September 25, 2026 to be acquired by private equity firm Madison Dearborn Partners in an all-cash transaction. The deal would take TMC private and delist its stock from the New York Stock Exchange, and the filing says the deal may not be completed.
Agreement announced September 25, 2026 with Madison Dearborn Partners, a Chicago-based private equity firm
Transaction is expected to close in the first half of 2027 or earlier, subject to conditions
Closing requires approval of TMC stockholders, regulatory approvals and certain change-of-control approvals
TMC common stock will no longer be listed on the New York Stock Exchange after closing; the filing says there is no guarantee the deal will close
The Marygold Companies, Inc. (TMC), which indirectly owns the general partner of United States Oil Fund, LP, announced a definitive agreement to be acquired by Madison Dearborn Partners in an all-cash transaction. TMC would become privately held and its stock would stop trading on the New York Stock Exchange, but the filing says the deal may not be completed within the expected time frame or at all.
Announced September 25, 2026: TMC to be acquired by Madison Dearborn Partners (MDP) in an all-cash transaction
TMC owns USCF Investments, Inc., the holding company of United States Commodity Funds LLC, the general partner of USO
Expected to close in the first half of 2027 or earlier, subject to TMC stockholder approval, regulatory approvals and change-of-control approvals
After closing, TMC's common stock would no longer be listed on the NYSE
The Marygold Companies (TMC), which owns the general partner of United States Brent Oil Fund, agreed on September 25, 2026 to be acquired by private equity firm Madison Dearborn Partners in an all-cash deal that would make TMC privately held. The transaction is expected to close in the first half of 2027 or earlier, but the filing states there is no guarantee it will be completed on that timeline or at all.
Deal is an all-cash transaction with Madison Dearborn Partners, announced September 25, 2026
Expected close: first half of 2027 or earlier, subject to TMC stockholder approval, regulatory approvals and change-of-control approvals
TMC common stock would no longer be listed on the New York Stock Exchange after closing
TMC and MDP indicate that TMC's transformation strategy to refocus USCF's business will be pursued after closing
Dyadic International received two Nasdaq deficiency notices on September 25, 2026: one for its stock trading below the $1 minimum bid price for 30 consecutive business days, and one for its market value of listed securities falling below $35 million over the same period. Both notices have no immediate effect on the common stock's listing on the Nasdaq Capital Market, but the company must regain compliance by March 24, 2027 or face delisting notice.
Bid price below $1 per share for the last 30 consecutive business days under Nasdaq Rule 5550(a)(2)
Market value of listed securities below the $35 million minimum for the last 30 consecutive business days under Rule 5550(b)(2)
Compliance Date is March 24, 2027, requiring 10 consecutive business days at or above the thresholds
Company may appeal any delisting determination to a Nasdaq hearings panel, with no assurance of success
Nasdaq notified Fusemachines on September 24, 2026 that its securities are subject to delisting because it did not meet the $50,000,000 minimum market value of listed securities as of September 23, 2026, the deadline for regaining compliance. The company plans to request a hearing before a Nasdaq Hearings Panel, which would pause delisting action, but the filing says there is no assurance the panel will grant continued listing or that the company will regain compliance.
Nasdaq first notified the company on March 27, 2026 that it no longer met the $50,000,000 MVLS requirement
Compliance deadline was September 23, 2026; Nasdaq said the company remained non-compliant as of that date
Company plans to timely request a hearing before the Nasdaq Hearings Panel, which would stay delisting action until the hearing and any panel extension expire
Calidi Biotherapeutics received a notice from NYSE American on September 21, 2026, saying it does not meet the $4.0 million stockholders' equity requirement, as it reported $3.1 million as of June 30, 2026. The company must submit a compliance plan by October 21, 2026, and regain compliance by March 21, 2028, or face delisting proceedings, which raises the risk of delisting for shareholders.
Stockholders' equity was $3.1 million as of June 30, 2026, below the $4.0 million NYSE American requires for companies with net losses in three of four recent fiscal years
Notice received September 21, 2026; plan of compliance due October 21, 2026
Company must regain compliance by March 21, 2028; delisting proceedings begin if no plan is submitted or accepted
Common stock continues to trade as CLDI with a ".BC" designation for noncompliance
Paramount Skydance Corporation said it will move the listing of its Class B common stock from Nasdaq to the NYSE, with Nasdaq trading ending at market close on or about October 5, 2026 and NYSE trading beginning on or about October 6, 2026. The company also set an October 5, 2026 record date for a distribution of about 470 million warrants to Class B holders, with issuance expected on or about October 13, 2026, but the distribution depends on the closing of the Warner Bros. Discovery acquisition, whose timing is not certain.
Nasdaq trading in Class B common stock expected to end at market close on or about October 5, 2026
NYSE trading expected to begin at market open on or about October 6, 2026
Record date October 5, 2026; warrants of about 470 million expected to be issued on or about October 13, 2026, one warrant per share held
Warrant exercise price set at the 20-day VWAP before the WBD Merger closing, capped at $16.02 and floored at $12.00; the distribution may be cancelled or postponed
Netcapital Inc. received a Nasdaq notice on September 21, 2026, saying it is not in compliance with the rule requiring timely periodic reports because it has not filed its quarterly report for the period ended July 31, 2026, and remains delinquent on its annual report for the fiscal year ended April 30, 2026. The notice has no immediate effect on the stock, which continues to trade on the Nasdaq Capital Market as NCPL, but the company must submit a compliance plan by October 23, 2026, and there is no assurance Nasdaq will accept it.
Nasdaq notice received September 21, 2026, citing Listing Rule 5250(c)(1)
Company must submit a plan to regain compliance by October 23, 2026
If accepted, Nasdaq may allow an exception until February 9, 2027; if not, the company can appeal to a Nasdaq Hearings Panel
Stock continues to trade on the Nasdaq Capital Market under NCPL for now
CleanSpark's subsidiary CSDC Finance I, LLC closed a private offering of $2.276 billion in 7.875% senior secured notes due October 1, 2031, priced at 98.500% of principal. Proceeds are intended to finance the remaining cost of the Sandersville Facility, a Georgia data center, reimburse prior equity contributions, and fund debt service reserves. The notes are secured obligations of the issuer, and CleanSpark has agreed to a completion guarantee for the facility if funding falls short.
Principal of $2,276.0 million sold at 98.500% of par, with interest of 7.875% per year paid semiannually from April 1, 2027
Notes mature October 1, 2031; issuer may redeem on or after October 1, 2028, with a make-whole premium before that date
Indenture limits additional debt, dividends, asset sales and affiliate transactions; change of control triggers an offer to repurchase at 101% of principal
CleanSpark will provide a completion guarantee for the Sandersville Facility, funding the issuer if proceeds and prior equity contributions are insufficient
On September 21, 2026, Titan subsidiaries agreed to sell all equity of Italtractor ITM S.p.A. to USCO S.p.A. for $207 million in cash, plus up to $6 million in earnout tied to ITM's 2026 performance. The deal is expected to close in January 2027, subject to regulatory approvals, and Titan intends to use the proceeds to reduce debt and strengthen its balance sheet. The filing does not disclose ITM's financial results, and the same day Chief Operating Officer Max Narancich announced his resignation effective October 9, 2026.
Purchase price of $207 million in cash, plus up to $6 million in earnout based on ITM's 2026 performance criteria
Closing expected in January 2027, subject to antitrust and foreign direct investment approvals
Titan intends to use a portion of the proceeds to reduce existing debt
Max Narancich resigns as Chief Operating Officer - Titan Specialty, effective October 9, 2026
SANUWAVE Health received a Nasdaq notice on September 23, 2026, because its Market Value of Listed Securities was below $50 million for 30 consecutive business days, the minimum for continued listing on The Nasdaq Global Market. The notice has no immediate effect on the listing, but if the company does not regain compliance by March 22, 2027, it will receive a delisting notice, and the company cannot guarantee it will keep its listing.
Nasdaq notice received September 23, 2026, citing Listing Rule 5450(b)(2)(A)
Company must close at or above $50 million MVLS for 10 consecutive business days to regain compliance
Compliance period runs 180 calendar days from the notice, until March 22, 2027
Company may consider transferring to The Nasdaq Capital Market if it meets that market's requirements
NextCure filed a petition on September 14, 2026 in the Delaware Court of Chancery asking the court to validate its July 2025 reverse split and the shares issued in reliance on it. The company says a 2026 change to Delaware law creates uncertainty over whether a higher supermajority vote standard should have applied to the 2025 approval, which could affect its pending business combination with Avere Therapeutics and its capitalization. The filing describes the court hearing as the venue where the uncertainty will be addressed.
Petition filed September 14, 2026 under Section 205 of the Delaware General Corporation Law; the court ordered notice to stockholders on September 21, 2026.
The 2025 reverse split amendment received about 89.92% of votes cast and about 64.76% of outstanding shares, short of the 66 2/3% supermajority standard in the charter.
Hearing set for 3:00 p.m. Eastern Time on November 6, 2026 in Wilmington, Delaware.
Stockholders wishing to oppose the petition must file a written submission by October 27, 2026, or appear at the hearing.
Monster Beverage said Rob Gehring, its Chief Executive Officer, Americas, will resign effective November 30, 2026, to return to The Coca-Cola Company as president of its North America operating unit. Emelie C. Tirre, Chief Strategy Officer, will take on the Americas and the Caribbean on an interim basis starting December 1, 2026, which matters to shareholders because it is a senior leadership change in the company's largest region's management.
Rob Gehring gave notice on September 21, 2026, and remains in his role through November 30, 2026.
Gehring will join The Coca-Cola Company as president of its North America operating unit.
Emelie C. Tirre, Chief Strategy Officer, will lead the Americas and the Caribbean on an interim basis effective December 1, 2026.
Tirre previously served as Chief Commercial Officer of the Americas, the Caribbean and Oceania through February 24, 2026.
Circle Internet Group said CFO Jeremy Fox-Geen intends to step down, and he will stay in the role through the end of December 2026 unless a successor is appointed sooner. The company has started a search for a new CFO with an executive search firm, and it also disclosed that co-founder P. Sean Neville resigned from the Board, reducing its size from eight to seven directors.
Jeremy Fox-Geen, CFO for more than five years, will remain CFO through December 31, 2026, or until a successor is appointed
Under a Post-Termination Restrictive Covenant Agreement, he will receive an aggregate cash payment of $1,050,000 paid over 12 months after his resignation date
P. Sean Neville, a co-founder and director since 2016, resigned from the Board effective September 25, 2026; the Company said the departure was not due to any disagreement
CoreCivic CEO Patrick Swindle resigned as President, CEO and director effective September 24, 2026, due to health reasons. Lucibeth Mayberry, the company's Executive Vice President and Chief Strategy Officer, was named President and CEO and appointed to the Board on the same date, and she said she is committed to continuing the current capital allocation strategy.
Swindle resigned as President, CEO and Board member effective September 24, 2026, due to health reasons.
Mayberry, Executive Vice President and Chief Strategy Officer since May 2025, became President and CEO effective September 24, 2026, with an annual base salary of $900,000.
Mayberry's short-term cash incentive target is 135% of her base salary; her 2027 long-term equity grant is about $2.5 million.
Swindle will serve as Special Advisor through September 24, 2028, and will receive $2,293,270 in cash and an $8,059,609 lump sum in exchange for forfeited equity awards, subject to a release of claims.
BCB Bancorp, Inc. said its bank agreed between September 21 and September 24, 2026 to sell problem loan portfolios with an aggregate unpaid principal balance of about $205.3 million as of June 30, 2026, with six purchasers. The company estimates a pre-tax loss of $43.3 million from the sales, to be recorded in the third quarter of 2026, and says the sales reduce balance sheet risk.
Six definitive agreements with six different purchasers; aggregate unpaid principal balance of about $205.3 million as of June 30, 2026
Portfolios include $180.7 million of commercial and multifamily real estate loans, $14.8 million of C&I loans, and $9.8 million of construction loans
Estimated pre-tax loss of $43.3 million, to be recorded in the third quarter of 2026
Five of the six sale transactions have closed; the last is expected to close before the end of the third quarter of 2026
Fathom Holdings and Neighborhood Intelligence (NXH) said on September 24, 2026, that they agreed to explore an alternative transaction in place of the merger agreement signed June 16, 2026. Under the proposal, NXH would contribute digital assets, led by its stake in tZERO, in exchange for newly issued Fathom shares, and would keep a controlling interest in Fathom. For shareholders, the original share exchange would be replaced by a deal that could change Fathom's ownership and control, and the companies say there is no assurance it will be completed.
The Original Merger Agreement, dated June 16, 2026, would be terminated once definitive documents are signed.
NXH's digital assets would be ascribed no less than $130 million in value, driven mainly by its approximately 38.8% direct and indirect stake in tZERO, subject to Fathom's validation.
NXH expects to keep a controlling interest in Fathom, and the final share count will be set in definitive agreements.
The deal remains subject to definitive agreements, Fathom and NXH board and Fathom stockholder approvals, an independent fairness opinion, and regulatory approvals.
Seth Bernstein will retire as CEO of AllianceBernstein effective March 31, 2027, and will step down as head of asset management at Equitable Holdings. Onur Erzan, currently AB's President and a member of Equitable's Management Committee, will become AB's CEO and President effective April 1, 2027. At the September 23, 2026 annual meeting, shareholders elected all nine director nominees, ratified PricewaterhouseCoopers as auditor, and approved the advisory vote on executive pay.
Seth Bernstein retires as AB CEO effective March 31, 2027, and steps down as Equitable's head of asset management; he will remain on the AB Board.
Onur Erzan named AB CEO and President effective April 1, 2027, with a fiscal 2027 total compensation target of $13.5 million and a base salary of $650,000.
Bernstein's retirement agreement includes a $2.5 million AB Holding unit award and 26 weeks of salary continuation totaling $325,000, subject to compliance conditions.
Annual meeting on September 23, 2026: PricewaterhouseCoopers ratified with 241,391,012 votes for and 7,850,494 against; say-on-pay approved with 235,558,213 votes for.
AllianceBernstein said CEO Seth Bernstein will retire on March 31, 2027, and President Onur Erzan will succeed him as President and Chief Executive Officer effective April 1, 2027. Bernstein will remain on the AB Board of Directors, and Erzan will join the board on the same date, so shareholders face a planned leadership transition rather than a change in reported financial results.
Seth Bernstein retires as CEO effective March 31, 2027; he will continue on the AB Board of Directors.
Onur Erzan, age 50, has been AB's President since January 5, 2026 and will become President and CEO effective April 1, 2027.
Erzan's fiscal 2027 total compensation target is $13.5 million, including a $650,000 base salary and a $5.8 million cash bonus.
Bernstein's retirement agreement includes a $2.5 million restricted unit grant and a $1.0 million 2026 Equitable Holdings award; AB reported $919 billion in assets under management as of August 31, 2026.
Blue Acquisition Corp. furnished an updated September 2026 investor presentation for its pending business combination with Blockfusion, which follows a Sixth Amendment to the Business Combination Agreement dated September 21, 2026. The presentation highlights a 15-year anchor lease with CoreWeave for 85MW of critical IT load, with anticipated revenue of about $2.8 billion over the initial lease terms, and notes that Blockfusion's financial information is unaudited while a PCAOB audit is underway.
Sixth Amendment to the Business Combination Agreement dated September 21, 2026; earlier amendments ran from March 19, 2026 to September 2, 2026
CoreWeave 15-year anchor lease covers 85MW take-or-pay critical IT load; anticipated revenue about $2.8 billion over initial terms, about $5.4 billion if all renewal options are exercised
CoreWeave committed $50 million of capital in a non-recurring charge and $30 million through purchase of a warrant
Blockfusion's financial information is unaudited and subject to change pending the PCAOB audit process
Nektar Therapeutics disclosed that a federal jury found Eli Lilly breached the implied covenant of good faith and fair dealing in their license agreement for rezpegaldesleukin. The jury awarded Nektar $90 million in damages plus interest, to be determined by the court. The verdict remains subject to post-trial proceedings and possible appeal, so the amount Nektar ultimately receives is not yet certain.
Jury verdict returned September 24, 2026 in Nektar Therapeutics v. Eli Lilly & Co., Case No. 3:23-cv-03943-JD
Jury awarded Nektar $90 million in damages plus interest, with interest to be set by the District Court
Verdict is subject to post-trial proceedings and any resulting judgment may be appealed
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.